This confirmed a mechanism: IL-6 major through p-STAT3 rather than p-STAT1 pathway affecting severity of inflammation and carcinogenesis in liver disease, particularly in HCC patients [12,16,29]. The gene discussed is STAT1; the disease is liver disorder.